Zheng Quan Zhi Xing·2025-07-11 16:13Core Viewpoint - The controlling shareholder, Shi Chunbao, has increased his stake in Chunli Medical from 55.92% to 56.22%, triggering a 1% threshold change in equity [1][2]. Group 1: Shareholder Information - The controlling shareholder is Shi Chunbao, with an increase in shareholding from 11,904.5093 thousand shares (31.04%) to 12,020.9043 thousand shares (31.34%) [2]. - The consistent shareholder, Yue Shujun, maintained her stake at 9,544.7900 thousand shares (24.88%) [2]. - The total shareholding of both shareholders increased from 21,449.2993 thousand shares (55.92%) to 21,565.6943 thousand shares (56.22%) [2]. Group 2: Equity Change Details - The equity change occurred between May 6, 2025, and July 10, 2025, through self-funded purchases via centralized bidding [1][2]. - The increase in shareholding does not violate any prior commitments or plans made by the shareholders [1]. - The change does not trigger mandatory tender offer obligations under relevant regulations [1]. Group 3: Regulatory Compliance - The equity change does not require the disclosure of an equity change report as per the "Measures for the Administration of Acquisitions of Listed Companies" and other relevant regulations [2]. - The company will continue to monitor the situation and fulfill its information disclosure obligations as required [2].